218 related articles for article (PubMed ID: 20022991)
21. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
Ribeiro RS; Abucham J
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
[TBL] [Abstract][Full Text] [Related]
22. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
23. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
[TBL] [Abstract][Full Text] [Related]
24. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
Jap TS; Chiu CY; Lirng JF; Won GS
J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
[TBL] [Abstract][Full Text] [Related]
25. PROKR2 mutations in autosomal recessive Kallmann syndrome.
Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
[TBL] [Abstract][Full Text] [Related]
26. Biallelic PROKR2 variants and congenital hypogonadotropic hypogonadism: a case report and a literature review.
Sugisawa C; Taniyama M; Sato T; Takahashi Y; Hasegawa T; Narumi S
Endocr J; 2022 Jul; 69(7):831-838. PubMed ID: 35236788
[TBL] [Abstract][Full Text] [Related]
27. Isolated cryptorchidism: no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism.
Laitinen EM; Tommiska J; Virtanen HE; Oehlandt H; Koivu R; Vaaralahti K; Toppari J; Raivio T
Mol Cell Endocrinol; 2011 Jul; 341(1-2):35-8. PubMed ID: 21664240
[TBL] [Abstract][Full Text] [Related]
28. The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons.
Wen Y; Zhang Z; Li Z; Liu G; Tao G; Song X; Xu Z; Shang Z; Guo T; Su Z; Chen H; You Y; Li J; Yang Z
J Comp Neurol; 2019 Dec; 527(18):2931-2947. PubMed ID: 31132148
[TBL] [Abstract][Full Text] [Related]
29. PROK2/PROKR2 Signaling and Kallmann Syndrome.
Dodé C; Rondard P
Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
[TBL] [Abstract][Full Text] [Related]
30. Prokineticins in central and peripheral control of human reproduction.
Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
[TBL] [Abstract][Full Text] [Related]
31. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
[TBL] [Abstract][Full Text] [Related]
32. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
[TBL] [Abstract][Full Text] [Related]
33. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions.
Semple RK; Topaloglu AK
Clin Endocrinol (Oxf); 2010 Apr; 72(4):427-35. PubMed ID: 19719764
[TBL] [Abstract][Full Text] [Related]
34. Prokr2-deficient mice display vascular dysmorphology of the fetal testes: potential implications for Kallmann syndrome aetiology.
Svingen T; McClelland KS; Masumoto K; Sujino M; Nagano M; Shigeyoshi Y; Koopman P
Sex Dev; 2011; 5(6):294-303. PubMed ID: 22223120
[TBL] [Abstract][Full Text] [Related]
35. Eight rare urinary disorders in a patient with Kallmann syndrome: A case report.
Tian H; Yan Z; Lv Y; Sun L; Gang X; Wang G
Medicine (Baltimore); 2020 Oct; 99(43):e22936. PubMed ID: 33120852
[TBL] [Abstract][Full Text] [Related]
36. The novel function of miR-3195 for mutant PROK2 (c.223-4C>A) degradation.
Zhou S; Li P
Cell Biol Int; 2021 Feb; 45(2):404-410. PubMed ID: 33140874
[TBL] [Abstract][Full Text] [Related]
37. Kallmann syndrome with a Tyr113His PROKR2 mutation.
Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
[TBL] [Abstract][Full Text] [Related]
38. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.
Costa-Barbosa FA; Balasubramanian R; Keefe KW; Shaw ND; Al-Tassan N; Plummer L; Dwyer AA; Buck CL; Choi JH; Seminara SB; Quinton R; Monies D; Meyer B; Hall JE; Pitteloud N; Crowley WF
J Clin Endocrinol Metab; 2013 May; 98(5):E943-53. PubMed ID: 23533228
[TBL] [Abstract][Full Text] [Related]
39. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
[TBL] [Abstract][Full Text] [Related]
40. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Okumura T; Ikeda M; Okochi T; Kinoshita Y; Kawashima K; Yamanouchi Y; Ozaki N; Iwata N
Neuromolecular Med; 2009; 11(2):114-22. PubMed ID: 19544013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]